Ionis Pharmaceuticals financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$42.62M $40.13M $14.86M $58.34M $107.19M $121.60M $108.47M $99.09M $102.05M $147.29M $214.16M $283.70M $372.78M $514.18M $599.67M $1.12B $729.26M $810.46M $587.37M $787.65M $0.00M
GM % Gross Margin %
-177.95% -83.98% 0.00% -22.14% 8.55% -4.19% -26.35% -56.91% -54.47% -20.67% -12.27% -13.21% 8.25% 27.22% 30.69% 58.32% 26.37% 20.65% -43.90% -15.17% 0.00%
OM Operating Margin
-200.42% -120.90% 0.00% -54.90% -10.50% -22.07% -43.18% -69.81% -66.73% -30.80% -21.68% -26.32% -4.79% 6.12% -10.10% 32.79% -19.52% -0.44% -69.49% -44.70% 0.00%
EPS Earnings Per Share
$-1.05 $-0.83 $-1.63 $-0.13 $1.58 $-0.62 $-0.85 $-0.65 $-0.55 $-0.40 $-0.74 $-0.68 $-0.05 $-0.13 $2.19 $-0.35 $0.82 $-2.19 $-2.71 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 -0.00% -0.00% 0 0.00% -0.00% 0 0 -0.00% 0 -0.00% -0.00% -0.00% -0.00% 0.00% -0.00% 0.00% -0.00% -0.00% 0
Sha. Shares
57.28m 72.2m 75.91m 86.95m 97m 98.38m 99.23m 99.73m 101.21m 116.07m 118.14m 120.12m 121.2m 124.8m 137.57m 140.66m 139.82m 141.21m 141.8m 143.47m 145.75m
OCF Operating Cash Flow
$-101.75M $-61.04M $-53.23M $36.09M $212.03M $-108.44M $-63.59M $-111.93M $1.88M $63.49M $6.29M $21.13M $-112.11M $174.15M $602.91M $345.63M $35.89M $30.80M $-274.37M $-307.51M $0.00M
FCF Free Cash Flow
$-105.28M $-61.46M $-54.27M $33.80M $198.36M $-121.85M $-76.83M $-122.13M $0.40M $61.94M $-1.23M $13.43M $-119.21M $139.39M $589.28M $314.82M $772.00M $18.84M $-290.09M $-166.20M $0.00M
FCFS Free Cash Flow Per Share
$-1.97 $-1.02 $-0.75 $0.37 $2.06 $-1.27 $-0.82 $-1.26 $-0.03 $0.53 $-0.04 $0.08 $-1.02 $1.10 $4.42 $2.21 $-0.04 $0.09 $-2.08 $-2.34 $0.00